Obesity Trial, Recruiting NCT06923644 Sponsor: Maastricht University Medical Center Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06923644
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults (men and women) with a BMI of 25 or above but below 40 (meaning they are overweight or moderately obese)
  • People whose health profile matches one of the specific metabolic types being studied in this trial (determined by a classification process)
  • People whose weight has been stable (within about 3 kg) for at least the past 3 months

Who may not be able to join:

  • People who have been diagnosed with, or are showing early signs of, type 1 or type 2 diabetes, based on blood sugar or related test results
  • People with kidney or liver problems (either previously diagnosed or found through blood tests)
  • People with digestive or gut diseases, or who have had abdominal surgery (though minor surgeries like appendix or gallbladder removal are generally allowed)
  • People with food allergies, food intolerances (including gluten or lactose intolerance), or eating disorders that could interfere with the study
  • People with heart disease or cancer (minor non-invasive skin cancer may be allowed)
  • People with high blood pressure above certain levels, whether or not they are on medication for it
  • People with conditions that affect how the body processes sugar or fats (confirm with trial site)
  • People with a serious illness where life expectancy may be less than 5 years
  • People with major mental health conditions
  • People taking medication for thyroid disease (though people with well-managed underactive thyroid may be allowed)
  • People with other physical or mental health conditions that could affect the study results
  • People taking certain medications known to affect blood sugar or fat metabolism, including some diabetes medications, certain cholesterol-lowering drugs, or regular use of anti-inflammatory painkillers (confirm with trial site for your specific medications)
  • People taking certain blood-thinning medications (other than low-dose aspirin)
  • People taking antidepressants, unless they have been on a stable dose for at least 3 months before and throughout the study
  • People taking statins (cholesterol medication), unless they have been on a stable dose for at least 3 months before and throughout the study
  • People who have been on long-term steroid treatment (more than 7 days in a row)
  • People who have taken antibiotics within the past 3 months
  • People who exercise at a moderate-to-vigorous level for more than 4 hours per week
  • People following a special or restricted diet (such as vegetarian, vegan, Atkins, or similar) that would conflict with the study diet
  • People who are planning to lose or gain more than 5% of their body weight during the study
  • People who drink more than 14 units of alcohol per week, or who use recreational drugs (including cannabis)
  • People who are not willing to limit alcohol to no more than 7 drinks per week during the study
  • People who smoke regularly, including use of e-cigarettes or vapes
  • People who regularly take strong vitamin supplements or dietary supplements (such as pro- or prebiotics) that could affect the study results
  • Women who are pregnant, breastfeeding, or planning to become pregnant
  • People who are unable or unwilling to follow the study diet
  • People who have donated blood in the last 3 months
  • People who have taken part in another similar study in the last 3 months
  • People who are unable to understand the study information or communicate with the study team
  • People who are unwilling to be randomly assigned to a study group or to sign a consent form
  • People who are unwilling to allow their data to be stored for 15 years
  • People considered unsuitable for any other reason, as decided by the study doctor or lead researcher

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
23 April 2025
Est. completion
1 April 2027

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Matsuda Index

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov